Comerica Bank Biogen Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Biogen Inc. stock. As of the latest transaction made, Comerica Bank holds 39,431 shares of BIIB stock, worth $6.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

39,431

Previous 40,898 3.59%

Holding current value

$6.3 Million

Previous $9.48 Million 19.38%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $277,365 - $347,385	-1,467 Reduced 3.59%	39,431 $7.64 Million
Q2 2024 Aug 15, 2024	SELL	$190.52 - $236.72 $269,776 - $335,195	-1,416 Reduced 3.35%	40,898 $9.48 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $256,544 - $323,929	1,210 Added 2.94%	42,314 $9.12 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $673,334 - $810,518	3,025 Added 7.94%	41,104 $10.6 Million
Q3 2023 Nov 21, 2023	BUY	$253.3 - $285.89 $9.65 Million - $10.9 Million	38,079 New	38,079 $9.79 Million
Q4 2022 Jan 26, 2023	BUY	$252.44 - $306.72 $1.5 Million - $1.82 Million	5,949 Added 33.06%	23,944 $0
Q3 2022 Oct 28, 2022	BUY	$194.69 - $268.46 $114,867 - $158,391	590 Added 3.39%	17,995 $4.94 Million
Q2 2022 Aug 02, 2022	BUY	$187.54 - $223.02 $264,806 - $314,904	1,412 Added 8.83%	17,405 $3.83 Million
Q1 2022 Apr 27, 2022	SELL	$193.77 - $244.14 $38,947 - $49,072	-201 Reduced 1.24%	15,993 $3.37 Million
Q4 2021 Feb 18, 2022	SELL	$223.92 - $287.77 $1.3 Million - $1.67 Million	-5,813 Reduced 26.41%	16,194 $3.89 Million
Q3 2021 Nov 22, 2021	SELL	$282.99 - $369.05 $472,876 - $616,682	-1,671 Reduced 7.06%	22,007 $6.23 Million
Q2 2021 Aug 26, 2021	SELL	$259.0 - $414.71 $510,489 - $817,393	-1,971 Reduced 7.68%	23,678 $8.2 Million
Q1 2021 Apr 28, 2021	SELL	$242.95 - $284.63 $398,438 - $466,793	-1,640 Reduced 6.01%	25,649 $7.18 Million
Q4 2020 Jan 28, 2021	SELL	$236.26 - $355.63 $575,765 - $866,670	-2,437 Reduced 8.2%	27,289 $6.68 Million
Q3 2020 Oct 30, 2020	SELL	$264.77 - $305.71 $247,559 - $285,838	-935 Reduced 3.05%	29,726 $8.43 Million
Q2 2020 Jul 31, 2020	SELL	$258.66 - $342.55 $295,648 - $391,534	-1,143 Reduced 3.59%	30,661 $8.2 Million
Q1 2020 May 01, 2020	SELL	$268.85 - $341.04 $273,958 - $347,519	-1,019 Reduced 3.1%	31,804 $10.1 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $500,636 - $691,759	-2,275 Reduced 6.48%	32,823 $9.74 Million
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $621,660 - $697,252	-2,859 Reduced 7.53%	35,098 $8.17 Million
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $769,050 - $847,712	-3,507 Reduced 8.46%	37,957 $0
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $125,041 - $195,579	-577 Reduced 1.37%	41,464 $0
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $33,698 - $42,682	121 Added 0.29%	42,041 $14.1 Million
Q3 2018 Nov 01, 2018	SELL	$293.51 - $383.83 $4.01 Million - $5.25 Million	-13,679 Reduced 24.6%	41,920 $13.3 Million
Q2 2018 Aug 01, 2018	SELL	$257.52 - $306.91 $233,828 - $278,674	-908 Reduced 1.61%	55,599 $19.7 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $55,407 - $78,364	213 Added 0.38%	56,507 $15 Million
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $703,880 - $788,399	-2,288 Reduced 3.91%	56,294 $19.5 Million
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $16.5 Million - $19.3 Million	58,582	58,582 $18.5 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account